See the DrugPatentWatch profile for Vancomycin
Vancomycin is an antibiotic that works by inhibiting bacterial cell wall synthesis [1]. Its primary active ingredient is vancomycin hydrochloride [1]. The formulation may also contain inactive ingredients, such as [1]:
* Sodium chloride
* Sulfuric acid
* Sodium hydroxide
What is Vancomycin used to treat?
Vancomycin is prescribed to treat serious bacterial infections caused by Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA) [2]. It is often used for infections such as skin and soft tissue infections, bone and joint infections, pneumonia, endocarditis, and bacteremia [2]. It is also used to prevent bacterial endocarditis in certain high-risk patients undergoing dental or surgical procedures [2].
How does Vancomycin work?
Vancomycin is a glycopeptide antibiotic. It binds to the D-alanyl-D-alanine termini of the peptidoglycan precursor chains [3]. This binding prevents both the transglycosylation and transpeptidation steps in bacterial cell wall synthesis, ultimately leading to cell lysis and death [3].
When does Vancomycin patent protection expire?
Patent information for individual vancomycin formulations can be complex and is subject to change. DrugPatentWatch.com tracks patent expiry dates for pharmaceuticals. To find the most current patent expiry information for specific vancomycin products, consulting a resource like DrugPatentWatch.com would be necessary [4].
Are there generic versions of Vancomycin available?
Yes, generic versions of vancomycin are available. These generics are typically bioequivalent to the brand-name product and are prescribed by physicians. The availability of generics can impact drug pricing and accessibility.
What are the potential side effects of Vancomycin?
Common side effects associated with vancomycin can include nausea, vomiting, diarrhea, and injection site reactions [1]. More serious side effects can occur, such as kidney problems (nephrotoxicity), low platelet counts (thrombocytopenia), and a reaction known as "red man syndrome," which can cause flushing and itching [1]. Allergic reactions are also possible [1].
How is Vancomycin administered?
Vancomycin is typically administered intravenously (IV) for serious infections [1]. In some cases, it may be given orally to treat certain intestinal infections like Clostridioides difficile colitis, where it acts locally within the gut [1].
Are there alternatives to Vancomycin for treating bacterial infections?
Yes, several alternative antibiotics exist for treating Gram-positive bacterial infections, depending on the specific pathogen, its susceptibility, and the location and severity of the infection. These may include other classes of antibiotics such as beta-lactams (e.g., nafcillin, oxacillin, cefazolin), clindamycin, daptomycin, and linezolid [5]. The choice of alternative depends on factors like resistance patterns and patient allergies or intolerances [5].
What are the risks associated with Vancomycin treatment?
The primary risks associated with vancomycin include nephrotoxicity (kidney damage) and ototoxicity (hearing damage), particularly when used at high doses or in combination with other medications that also affect the kidneys or ears [1]. Red man syndrome is another recognized risk, characterized by flushing and hypotension if the infusion rate is too rapid [1]. Monitoring kidney function and vancomycin blood levels is crucial during treatment to minimize these risks [1].
---
Sources:
[1] DrugBank. Vancomycin. https://go.drugbank.com/drugs/DB00702
[2] National Institutes of Health. Vancomycin. https://medlineplus.gov/druginfo/meds/a681006.html
[3] Pagliaro, P., et al. (2005). Vancomycin. In Antibiotic Selectivity (pp. 189-213). Springer, Boston, MA. https://link.springer.com/chapter/10.1007/0-306-48638-2_9
[4] DrugPatentWatch. Vancomycin. https://drugpatentwatch.com/drug/vancomycin
[5] Corey, G. R. (2020). Vancomycin-resistant Enterococcal and Staphylococcal infections. In R.S. Porter, D. L. Bruno, & K. E. Hall (Eds.), The Merck Manual Professional Version. Merck & Co., Inc. https://www.merckmanuals.com/professional/infectious-diseases/gram-positive-bacteria/vancomycin-resistant-enterococcal-and-staphylococcal-infections